egov.mn

Divergent activation of the RXFP1 relaxin receptor by protein and small-molecule agonists | Science

This story was prepared automatically by software.

Divergent activation of the RXFP1 relaxin receptor by protein and small-molecule agonists | Science

The relaxin receptor RXFP1 is a therapeutic target owing to its potential benefits in the treatment of fibrosis and heart failure. Protein and small-molecule agonists are currently in midstage clinical trials for various forms of heart disease. In this ...

Source: https://www.science.org/doi/10.1126/science.aei0135

Share
Next storyMolecular adhesion for durable metal halide perovskite modules | Science
Newsletter

Get the latest news delivered to your inbox.

Related articles